Association between residual urinary volume and urinary tract infection: prospective trial in 225 male patients
Brookman-May S, Burger M, Hoschke B, Wieland WF, Kendel F, Gilfrich C, Braun KP, May M
Urologe A. 2010;49(9): 1163-8
Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
Brookman-May S, May M, Gilfrich C, Wieland WF, Burger M
Expert Rev Anticancer Ther. 2010;10(6): 813-23
Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer
Brookman-Amissah S, May M, Albrecht K, Herrmann T, Roigas J, Gilfrich CP, Pflanz S, Gunia S
World J Urol. 2010 Feb;28(1):103-9
The application of adjuvant autologous intravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial
Burger M, Thiounn N, Denzinger S, Kondas J, Benoit G, Chapado MS, Jimenez-Cruz FJ, Kisbenedek L, Szabo Z, Zsolt D, Grimm MO, Romics I, Thuroff JW, Kiss T, Tombal B, Wirth M, Munsell M, Mills B, Koh T, Sherman J
J Transl Med. 2010;8(1): 54
Editorial comment on: prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications
Burger M
Eur Urol. 2010;57(5): 858
Robot-assisted high-intensity focused ultrasound in focal therapy of prostate cancer
Chaussy CG, Thüroff S
J Endourol. 2010;24(5):843-7
High-intensity focused ultrasound in the management of prostate cancer
Chaussy CG, Thüroff S
Expert Rev Med Devices. 2010;7(2):209-17
Long-term follow-up of male patients after reconstruction of the bladder-exstrophy-epispadias complex: psychosocial status, continence, renal and genital function
Ebert AK, Schott G, Bals-Pratsch M, Seifert B, Rösch WH
J Pediatr Urol. 2010;6(1): 6-10
Pelvic-floor imaging using three-dimensional ultrasonography and magnetic resonance imaging in the long term follow-up of the bladder-exstrophy-epispadias complex
Ebert AK, Falkert A, Brandl R, Hirschfelder H, Koller M, Rösch WH
BJU Int. 2010;105(2): 248-53
Characteristics and outcomes of patients with clinical t1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort
Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF
Eur Urol. 2010;57(2): 300-9
Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder
Fritsche HM, Burger M, Dietmaier W, Denzinger S, Bach E, Otto W, Doblinger M, Schwarz S, Buchner H, Hartmann A
Am J Clin Pathol. 2010;134(4): 597-603
Do we have enough evidence to recommend the routine use of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer?
Ganzer R, Blana A
Eur Urol. 2010;58(6): 816-8
Neuroendocrine carcinoma of the seminal vesicles presenting with Lambert Eaton syndrome: a case report
Kreiner B, Denzinger S, Ganzer R, Fritsche HM, Burger M, Wieland WF, Otto W
J Med Case Reports. 2010;4: 320
Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre
Otto W, Fritsche HM, Dirmeyer M, Burger M, Straub M, Rössler W, Wieland WF, Denzinger S
Aktuelle Urol. 2010;41(5): 316-9
Ongoing outbreak of mumps affecting adolescents and young adults inBavaria,Germany, August to October 2010
Otto W, Mankertz A, Santibanez S, Saygili H, Wenzel J, Jilg W, Wieland W, Borgmann S
Euro Surveill. 2010;15(50)
Concordance of the Gleason score in prostate multibiopsy and definitive histology
May M, Brookman-May S, Lebentrau S, Gilfrich C, Loy V, Theissig F, Roigas J, Hoschke B, Burger M, Miller K
Aktuelle Urol. 2010;41(3): 184-92
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L
BJU Int. 2010;106(4): 493-9
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y
BJU Int. 2010;105(10): 1402-12
Predicting individual outcomes after radical cystectomy: an external validation of current nomograms
Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM
BJU Int. 2010;106(3): 342-8
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
Ikenberg K, Fritzsche FR, Zuerrer-Haerdi U, Hofmann I, Hermanns T, Seifert H, Müntener M, Provenzano M, Sulser T, Behnke S, Gerhardt J, Mortezavi A, Wild P, Hofstädter F, Burger M, Moch H, Kristiansen G
BMC Cancer. 2010;10: 341
Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting
May M, Brookman-May S, Hoschke B, Gilfrich C, Kendel F, Baxmann S, Wittke S, Kiessig ST, Miller K, Johannsen M
Cancer Immunol Immunother. 2010 May;59(5):687-95
Retroperitoneal bronchogenic cyst treated by laparoscopic surgery
Rud O, May M, Brookman-Amissah S, Moersler J, Greiner A, Gilfrich C
Chirurg. 2010 Mar;81(3):243-6
The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Muller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP
Clin Cancer Res. 2010; 16(17): 4461-7
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C
Eur J Med Res. 2010;15(6): 253-7
The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression
Catto JW, Abbod MF, Wild PJ, Linkens DA, Pilarsky C, Rehman I, Rosario DJ, Denzinger S, Burger M, Stoehr R, Knuechel R, Hartmann A, Hamdy FC
Eur Urol. 2010;57(3): 398-406
Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications
May M, Brookman-Amissah S, Roigas J, Hartmann A, Störkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Gunia S
Eur Urol. 2010;57(5):850-8
Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer
Engel J, Bastian PJ, Baur H, Beer V, Chaussy CG, Gschwend JE, Oberneder R, Rothenberger KH, Stief CG, Hölzel D
Eur Urol. 2010;57(5):754-61
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study
Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF
Eur Urol. 2010;57(6): 1064-71
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation
Schatz P, Dietrich D, Koenig T, Burger M, Lukas A, Fuhrmann I, Kristiansen G, Stoehr R, Schuster M, Lesche R, Weiss G, Corman J, Hartmann A
J Mol Diagn. 2010;12(3): 345-53
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review
Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A
J Urol. 2010;183(2): 460-6
Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study
Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G
J Urol. 2010;184(5): 1895-900
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer
Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB
J Urol. 2010;184(5): 1907-13
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients
Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
J Urol. 2010;183(5): 1757-63
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients
Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
J Urol. 2010;183(1): 87-93
Mutational activation of FGFR3 is not involved in the development of prostate cancer
Koufou S, Lunz JC, Borchardt A, Keck B, Kneitz B, Gaisa NT, Hafner C, Giedl C, Rau TT, Rogler A, Wieland WF, Hartmann A, Stoehr R
Pathobiology. 2010;77(5): 249-52
Patients with bladder cancer in clinical stage T2: survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens
May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Bastian PJ
Urologe A. 2010;49(12): 1508-15
Abscess-forming retroperitoneal actinomycosis after urogynaecological surgery
Rud O, May M, Brookman-May S, Mörsler J, Rotter M, Gilfrich C.
Urologe A. 2010 Oct;49(10):1283-6
A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy
Stolzenburg JU, Kallidonis P, Do M, Dietel A, Häfner T, Rabenalt R, Sakellaropoulos G, Ganzer R, Paasch U, Horn LC, Liatsikos E
Urology. 2010;76(3): 743-8
Evaluation of renocapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view
May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S
Urol Oncol. 2010 May-Jun;28(3):274-9
Modular therapy approach in metastatic castration-refractory prostate cancer
Walter B, Rogenhofer S, Vogelhuber M, Berand A, Wieland WF, Andreesen R, Reichle A
World J Urol. 2010;28(6): 745-50
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz@csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie@csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
